2.22
-0.02 (-0.89%)
-0.02 (-0.89%)
Upgrade to Real-Time
Afterhours
Low
0.76
High
5.68
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Xenetic Biosciences Inc | XBIO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.02 | -0.89% | 2.22 | 16:34:56 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.27 | 2.19 | 2.28 | 2.22 | 2.24 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 2.21 | 2.26 | 0.05 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 934 | 297,437 | $ 2.24 | $ 666,720 | - | 0.76 - 5.68 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:17:22 | formt | 158 | $ 2.21 | USD |
Period:
Draw Mode:
Xenetic Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 13.98M | 6.30M | 422.99k | $ 436.94k | $ - | -9.62 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 1.00 | 12.20% |
Xenetic Biosciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical XBIO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.34 | 2.42 | 2.17 | 2.28 | 414,384 | -0.12 | -5.13% |
| 1 Month | 3.12 | 3.1595 | 2.17 | 2.65 | 529,747 | -0.90 | -28.85% |
| 3 Months | 1.99 | 5.68 | 1.65 | 3.12 | 11,067,319 | 0.23 | 11.56% |
| 6 Months | 2.51 | 5.68 | 1.50 | 3.10 | 5,105,910 | -0.29 | -11.55% |
| 1 Year | 0.9118 | 5.68 | 0.76 | 3.01 | 2,860,544 | 1.31 | 143.47% |
| 3 Years | 3.60 | 16.8895 | 0.44 | 2.75 | 1,169,893 | -1.38 | -38.33% |
| 5 Years | 3.75 | 16.8895 | 0.44 | 2.85 | 764,152 | -1.53 | -40.8% |
Xenetic Biosciences Description
| Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a pipeline of therapeutic assets targeting oncology indications. It also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin resistant endometrial cancer. |
